BGM Group Ltd. (NASDAQ:BGM – Get Free Report)’s share price traded down 3.2% on Monday . The stock traded as low as $0.2425 and last traded at $0.2546. 17,468 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 329,014 shares. The stock had previously closed at $0.2630.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings cut BGM Group from a “sell (d)” rating to a “sell (e+)” rating in a research report on Thursday, August 6th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, BGM Group has a consensus rating of “Sell”.
BGM Group Stock Up 5.6%
BGM Group (NASDAQ:BGM – Get Free Report) last announced its quarterly earnings data on Friday, August 28th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $12.15 million for the quarter.
BGM Group Company Profile
Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.
Featured Stories
- Five stocks we like better than BGM Group
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
- 5 Buy-and-Hold Stocks Built to Weather a Volatile Market
- Movado’s Turnaround Gains Momentum
Receive News & Ratings for BGM Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BGM Group and related companies with MarketBeat.com's FREE daily email newsletter.
